Iconovo announced that BNC Korea has acquired rights to manufacture and market generic versions of Ultibro indacaterol/glycopyrronium and Seebri glycopyrronium DPIs based on Iconovo formulations and the company's ICOcap device. The deal covers a territory that includes Korea, Japan, China, Taiwan, Turkey, and Russia, as well as additional CIS and southeast Asian … [Read more...] about BNC Korea acquires rights to Iconovo’s generic versions of Ultibro and Seebri for Asia, CIS countries
Products and Services
Lonza announces new Center of Excellence for DPI particle engineering and formulation
Lonza Pharma & Biotech has established a new Center of Excellence for DPI development at its location in Bend, OR, USA, the company said. The site originally belonged to spray drying specialist Bend Research, which was acquired by Capsugel in 2013; Capsugel was subsequently acquired by Lonza in 2017. According to Lonza, "the core service offer is … [Read more...] about Lonza announces new Center of Excellence for DPI particle engineering and formulation
Koura announces donation of inhalers to Maharashtra government for COVID-19, innovation award for Zephex 152a
Medical propellant maker Koura announced that it has donated 10,000 MDIs to the government of the Indian state of Maharashtra to help meet the demand for inhalers during the COVID-19 pandemic. Specifically, the company said that the inhalers are designated for the Haffkine Institute in Mumbai. Koura also announced that it has won the Chemicals Northwest 2020 … [Read more...] about Koura announces donation of inhalers to Maharashtra government for COVID-19, innovation award for Zephex 152a
iPharma Labs announces addition of GMP testing services, new board members and management hires
Inhalation contract R&D company iPharma Labs has announced the introduction of new GMP testing services for testing and development of OINDPs, including inhaled drugs for the treatment of COVID-19. The company also announced the addition of two board members and two management hires with extensive experience in the inhaled drug delivery industry. The iPharma … [Read more...] about iPharma Labs announces addition of GMP testing services, new board members and management hires
Koura announces investment in Zephex HFA 152a propellant production
Propellant manufacturer Koura (formerly Mexichem) has announced a "multimillion-pound sterling investment" in a new cGMP production facility for Zephex HFA 152a medical propellant at the company's Runcorn, UK location. The new facility is expected to come online by late 2021, the company said. According to Koura, "This investment is part of a program to bring … [Read more...] about Koura announces investment in Zephex HFA 152a propellant production
Inhalation Sciences announces new agreement for project using DissolvIt lung simulation tool
Inhalation Sciences (ISAB) has announced that a "noted global pharma company" has placed an order worth €75,000 for a contract research project utilizing ISAB's DissolvIt system. The DissolvIt module is used to simulate dissolution and absorption of dry powder formulations in the lung and generates data including Cmax and Tmax curves. ISAB CEO Manoush Masarrat … [Read more...] about Inhalation Sciences announces new agreement for project using DissolvIt lung simulation tool
Respira Technologies launches RespiRx nebulizer platform
Vaping startup Respira Technologies has announced the launch of its RespiRx delivery device platform, which the company is aiming at pharmaceutical drug delivery "across the fullest spectrum of pressure and thermo sensitive APIs." The company, which has backing from several venture capital companies, says that it is now a "a platform device and biotechnology company … [Read more...] about Respira Technologies launches RespiRx nebulizer platform
Iconovo’s ICOcap DPI gets CE mark for clinical trial use
DPI developer Iconovo announced that the company's ICOcap capsule-based dry powder inhaler ICOcap is now CE marked for use in clinical trials. The ICOcap inhaler is available from the Stevanato Group, which signed a manufacturing, sales, and distribution agreement for the inhaler with Iconovo in 2018. Iconovo CEO Johan Wäborg commented, "Getting the CE … [Read more...] about Iconovo’s ICOcap DPI gets CE mark for clinical trial use
Propeller Health sensor for Symbicort gets 510(k) clearance
Propeller Health announced that the FDA has granted 510(k) clearance for the company's inhaler monitoring sensor for AstraZeneca's Symbicort MDI. The Propeller sensor snaps on to the inhaler and connects via Bluetooth to a mobile app. The company also manufactures sensors for MDIs, DPIs, and SMIs made by GSK, Novartis, Orion, and Boehringer Ingelheim. Propeller … [Read more...] about Propeller Health sensor for Symbicort gets 510(k) clearance
iCAIR consortium initiates project to develop inhaled drugs for COVID-19
A consortium called Fraunhofer International Consortium for Anti-Infective Research (iCAIR) -- composed of researchers from Fraunhofer ITEM, Griffith University, Hannover Medical School, and Twincore -- has announced that it has initiated a project to develop inhaled drugs to treat COVID-19, starting with high-throughput screening for candidates by temporary … [Read more...] about iCAIR consortium initiates project to develop inhaled drugs for COVID-19